omalizumabihoitoa
Omalizumab is a medication used to treat certain types of asthma and chronic spontaneous urticaria. It is a monoclonal antibody, a type of biologic therapy that targets and neutralizes immunoglobulin E (IgE), a key player in allergic reactions. By reducing IgE levels, omalizumab helps to prevent the release of inflammatory chemicals that cause symptoms of asthma and urticaria.
For asthma, omalizumab is typically prescribed for individuals with moderate to severe allergic asthma that is
The effectiveness of omalizumab is usually assessed by monitoring symptom improvement, such as a reduction in